Comments
Loading...

Insmed Analyst Ratings

INSMNASDAQ
Logo brought to you by Benzinga Data
$100.64
1.151.16%
At close: -
$99.00
-1.64-1.63%
After Hours: 7:20 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$120.00
Lowest Price Target1
$42.00
Consensus Price Target1
$96.21

Insmed Analyst Ratings and Price Targets | NASDAQ:INSM | Benzinga

Insmed Inc has a consensus price target of $96.21 based on the ratings of 21 analysts. The high is $120 issued by HC Wainwright & Co. on June 11, 2025. The low is $42 issued by Wolfe Research on February 15, 2024. The 3 most-recent analyst ratings were released by Goldman Sachs, Mizuho, and RBC Capital on June 11, 2025, respectively. With an average price target of $109.33 between Goldman Sachs, Mizuho, and RBC Capital, there's an implied 10.44% upside for Insmed Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
13
Feb
3
Mar
1
Apr
2
May
8
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Goldman Sachs
Mizuho
RBC Capital
Morgan Stanley
B of A Securities

1calculated from analyst ratings

Analyst Ratings for Insmed

Buy NowGet Alert
06/11/2025Buy Now13.13%Goldman Sachs
Andrea Tan39%
$100 → $112MaintainsBuyGet Alert
06/11/2025Buy Now11.11%Mizuho
Graig Suvannavejh51%
$96 → $110MaintainsOutperformGet Alert
06/11/2025Buy Now7.07%RBC Capital
Leonid Timashev39%
$99 → $106MaintainsOutperformGet Alert
06/11/2025Buy Now3.03%Morgan Stanley
Matthew Harrison60%
$90 → $102MaintainsOverweightGet Alert
06/11/2025Buy Now10.1%B of A Securities
Jason Zemansky77%
$94 → $109MaintainsBuyGet Alert
06/11/2025Buy Now20.2%Wells Fargo
Tiago Fauth47%
$107 → $119MaintainsOverweightGet Alert
06/11/2025Buy Now21.21%HC Wainwright & Co.
Andrew Fein45%
$90 → $120MaintainsBuyGet Alert
06/10/2025Buy Now16.16%Leerink Partners
Joseph Schwartz64%
$100 → $115MaintainsOutperformGet Alert
05/13/2025Buy Now6.06%Jefferies
Kelly Shi41%
→ $105Initiates → BuyGet Alert
05/09/2025Buy Now10.1%UBS
Trung Huynh42%
$110 → $109MaintainsBuyGet Alert
04/22/2025Buy Now-9.09%HC Wainwright & Co.
Andrew Fein45%
$90 → $90ReiteratesBuy → BuyGet Alert
03/20/2025Buy Now-3.03%B of A Securities
Jason Zemansky77%
$92 → $96MaintainsBuyGet Alert
03/19/2025Buy Now1.01%RBC Capital
Leonid Timashev39%
$100 → $100ReiteratesOutperform → OutperformGet Alert
03/06/2025Buy Now11.11%UBS
Trung Huynh42%
$105 → $110MaintainsBuyGet Alert
02/25/2025Buy Now1.01%RBC Capital
Leonid Timashev39%
→ $100Initiates → OutperformGet Alert
02/25/2025Buy Now2.02%Guggenheim
Vamil Divan74%
$101 → $101ReiteratesBuy → BuyGet Alert
02/24/2025Buy Now-9.09%HC Wainwright & Co.
Andrew Fein45%
$90 → $90ReiteratesBuy → BuyGet Alert
02/21/2025Buy Now9.09%Truist Securities
Nicole Germino64%
$105 → $108MaintainsBuyGet Alert
02/21/2025Buy Now-3.03%Stifel
Stephen Willey54%
$97 → $96MaintainsBuyGet Alert
02/21/2025Buy Now-9.09%HC Wainwright & Co.
Andrew Fein45%
$90 → $90ReiteratesBuy → BuyGet Alert
02/20/2025Buy Now—Cantor Fitzgerald
Jennifer Kim60%
—ReiteratesOverweight → OverweightGet Alert
02/19/2025Buy Now—Cantor Fitzgerald
Jennifer Kim60%
—ReiteratesOverweight → OverweightGet Alert
02/19/2025Buy Now8.08%Wells Fargo
Tiago Fauth47%
$85 → $107MaintainsOverweightGet Alert
02/11/2025Buy Now-2.02%Stifel
Stephen Willey54%
$88 → $97MaintainsBuyGet Alert
02/07/2025Buy Now-7.07%JP Morgan
Jessica Fye67%
$83 → $92MaintainsOverweightGet Alert
02/07/2025Buy Now2.02%Guggenheim
Vamil Divan74%
$95 → $101MaintainsBuyGet Alert
02/06/2025Buy Now-9.09%Morgan Stanley
Matthew Harrison60%
$85 → $90MaintainsOverweightGet Alert
11/22/2024Buy Now-16.16%JP Morgan
Jessica Fye67%
$74 → $83MaintainsOverweightGet Alert
11/01/2024Buy Now6.06%Truist Securities
Nicole Germino64%
$100 → $105ReiteratesBuy → BuyGet Alert
11/01/2024Buy Now-9.09%HC Wainwright & Co.
Andrew Fein45%
$90 → $90ReiteratesBuy → BuyGet Alert
10/11/2024Buy Now1.01%Truist Securities
Nicole Germino64%
$85 → $100MaintainsBuyGet Alert
10/09/2024Buy Now-13.13%B of A Securities
Jason Zemansky77%
$84 → $86MaintainsBuyGet Alert
10/03/2024Buy Now-25.25%JP Morgan
Jessica Fye67%
$72 → $74MaintainsOverweightGet Alert
09/09/2024Buy Now—Cantor Fitzgerald
Josh Schimmer57%
—Reiterates → OverweightGet Alert
08/29/2024Buy Now-9.09%HC Wainwright & Co.
Andrew Fein45%
$90 → $90ReiteratesBuy → BuyGet Alert
08/12/2024Buy Now-14.14%Truist Securities
Nicole Germino64%
$88 → $85MaintainsBuyGet Alert
08/12/2024Buy Now-9.09%HC Wainwright & Co.
Andrew Fein45%
$90 → $90ReiteratesBuy → BuyGet Alert
08/09/2024Buy Now-14.14%Wells Fargo
Tiago Fauth47%
$77 → $85MaintainsOverweightGet Alert
08/09/2024Buy Now-1.01%TD Cowen
Ritu Baral40%
$75 → $98MaintainsBuyGet Alert
08/09/2024Buy Now-15.15%UBS
Trung Huynh42%
$78 → $84MaintainsBuyGet Alert
08/09/2024Buy Now-11.11%Stifel
Stephen Willey54%
$74 → $88MaintainsBuyGet Alert
07/12/2024Buy Now-14.14%Morgan Stanley
Matthew Harrison60%
$60 → $85MaintainsOverweightGet Alert
07/10/2024Buy Now3.03%Goldman Sachs
Andrea Tan39%
$74 → $102MaintainsBuyGet Alert
07/09/2024Buy Now-4.04%Guggenheim
Vamil Divan74%
$70 → $95MaintainsBuyGet Alert
07/08/2024Buy Now-9.09%HC Wainwright & Co.
Andrew Fein45%
$70 → $90MaintainsBuyGet Alert
07/05/2024Buy Now-16.16%B of A Securities
Jason Zemansky77%
$83 → $83MaintainsBuyGet Alert
07/02/2024Buy Now-29.29%HC Wainwright & Co.
Andrew Fein45%
$70 → $70ReiteratesBuy → BuyGet Alert
07/01/2024Buy Now-11.11%Truist Securities
Nicole Germino64%
$68 → $88MaintainsBuyGet Alert
06/28/2024Buy Now-16.16%B of A Securities
Jason Zemansky77%
$62 → $83MaintainsBuyGet Alert
06/21/2024Buy Now-24.24%Evercore ISI Group
Josh Schimmer57%
$42 → $75MaintainsOutperformGet Alert
06/20/2024Buy Now—Cantor Fitzgerald
Jennifer Kim60%
—Reiterates → OverweightGet Alert
06/20/2024Buy Now-27.27%JP Morgan
Jessica Fye67%
$55 → $72MaintainsOverweightGet Alert
06/07/2024Buy Now-17.17%Mizuho
Graig Suvannavejh51%
$36 → $82MaintainsBuyGet Alert
06/05/2024Buy Now-25.25%Stifel
Stephen Willey54%
$67 → $74MaintainsBuyGet Alert
05/31/2024Buy Now-32.32%Stifel
Stephen Willey54%
$39 → $67MaintainsBuyGet Alert
05/29/2024Buy Now-32.32%TD Cowen
Ritu Baral40%
$45 → $67MaintainsBuyGet Alert
05/29/2024Buy Now-41.41%UBS
Trung Huynh42%
$46 → $58MaintainsBuyGet Alert
05/29/2024Buy Now-25.25%Goldman Sachs
Andrea Tan39%
$49 → $74MaintainsBuyGet Alert
05/29/2024Buy Now-22.22%Wells Fargo
Tiago Fauth47%
$55 → $77MaintainsOverweightGet Alert
05/29/2024Buy Now-31.31%Truist Securities
Nicole Germino64%
$48 → $68MaintainsBuyGet Alert
05/29/2024Buy Now-36.36%Barclays
Leon Wang64%
$40 → $63MaintainsOverweightGet Alert
05/29/2024Buy Now-44.44%JP Morgan
Jessica Fye67%
$36 → $55MaintainsOverweightGet Alert
05/29/2024Buy Now-37.37%B of A Securities
Jason Zemansky77%
$40 → $62MaintainsBuyGet Alert
05/29/2024Buy Now-29.29%HC Wainwright & Co.
Andrew Fein45%
$52 → $70MaintainsBuyGet Alert
05/28/2024Buy Now-39.39%Morgan Stanley
Matthew Harrison60%
$43 → $60MaintainsOverweightGet Alert
05/28/2024Buy Now-59.6%B of A Securities
Jason Zemansky77%
$40 → $40MaintainsBuyGet Alert
05/16/2024Buy Now-51.52%Truist Securities
Nicole Germino64%
$48 → $48MaintainsBuyGet Alert
05/15/2024Buy Now-50.51%Goldman Sachs
Andrea Tan39%
$40 → $49MaintainsBuyGet Alert
05/14/2024Buy Now-47.47%HC Wainwright & Co.
Andrew Fein45%
$52 → $52ReiteratesBuy → BuyGet Alert
05/13/2024Buy Now-63.64%Mizuho
Graig Suvannavejh51%
$35 → $36MaintainsBuyGet Alert
05/10/2024Buy Now-56.57%Morgan Stanley
Matthew Harrison60%
$40 → $43MaintainsOverweightGet Alert
04/23/2024Buy Now-51.52%Truist Securities
Nicole Germino64%
→ $48Initiates → BuyGet Alert
04/11/2024Buy Now-59.6%Barclays
Leon Wang64%
$37 → $40MaintainsOverweightGet Alert
04/01/2024Buy Now-44.44%Wells Fargo
Tiago Fauth47%
$55 → $55MaintainsOverweightGet Alert
02/27/2024Buy Now-45.45%Guggenheim
Vamil Divan74%
$52 → $54MaintainsBuyGet Alert
02/27/2024Buy Now-53.54%UBS
Trung Huynh42%
→ $46Initiates → BuyGet Alert
02/23/2024Buy Now-59.6%B of A Securities
Jason Zemansky77%
$37 → $40MaintainsBuyGet Alert
02/15/2024Buy Now-57.58%Wolfe Research
Andy Chen48%
→ $42Initiates → OutperformGet Alert
11/20/2023Buy Now-63.64%JP Morgan
Jessica Fye67%
→ $36Reinstates → OverweightGet Alert
10/27/2023Buy Now-64.65%Mizuho
Graig Suvannavejh51%
$33 → $35MaintainsBuyGet Alert
09/21/2023Buy Now-45.45%Cantor Fitzgerald
Jennifer Kim60%
$46 → $54MaintainsOverweightGet Alert
09/19/2023Buy Now-53.54%Cantor Fitzgerald
Jennifer Kim60%
→ $46ReiteratesOverweight → OverweightGet Alert
09/07/2023Buy Now-57.58%Evercore ISI Group
Josh Schimmer57%
$32 → $42MaintainsOutperformGet Alert
09/06/2023Buy Now-66.67%Mizuho
Graig Suvannavejh51%
$30 → $33MaintainsBuyGet Alert
09/06/2023Buy Now-62.63%B of A Securities
Jason Zemansky77%
$35 → $37MaintainsBuyGet Alert
09/06/2023Buy Now-47.47%HC Wainwright & Co.
Andrew Fein45%
→ $52ReiteratesBuy → BuyGet Alert
09/05/2023Buy Now-47.47%Guggenheim
Vamil Divan74%
$50 → $52ReiteratesBuy → BuyGet Alert
08/04/2023Buy Now-64.65%Stifel
Stephen Willey54%
$33 → $35MaintainsBuyGet Alert
08/04/2023Buy Now-58.59%Morgan Stanley
Matthew Harrison60%
$41 → $41ReiteratesOverweight → OverweightGet Alert
08/04/2023Buy Now-47.47%HC Wainwright & Co.
Andrew Fein45%
→ $52ReiteratesBuy → BuyGet Alert
07/26/2023Buy Now-69.7%Mizuho
Graig Suvannavejh51%
$28 → $30MaintainsBuyGet Alert
07/26/2023Buy Now-49.49%Guggenheim
Vamil Divan74%
→ $50Initiates → BuyGet Alert
05/09/2023Buy Now-47.47%HC Wainwright & Co.
Andrew Fein45%
→ $52Reiterates → BuyGet Alert
02/24/2023Buy Now-53.54%Cantor Fitzgerald
Jennifer Kim60%
$49 → $46MaintainsOverweightGet Alert
02/24/2023Buy Now-53.54%Credit Suisse
Judah Frommer64%
→ $46Reiterates → OutperformGet Alert
02/24/2023Buy Now-47.47%HC Wainwright & Co.
Andrew Fein45%
→ $52Reiterates → BuyGet Alert
01/20/2023Buy Now-64.65%Barclays
Leon Wang64%
$37 → $35MaintainsOverweightGet Alert
01/09/2023Buy Now-60.61%Goldman Sachs
Andrea Tan39%
$44 → $39MaintainsBuyGet Alert
12/09/2022Buy Now-71.72%Mizuho
Graig Suvannavejh51%
→ $28Initiates → BuyGet Alert
12/08/2022Buy Now-62.63%Barclays
Leon Wang64%
→ $37Initiates → OverweightGet Alert

FAQ

Q

What is the target price for Insmed (INSM) stock?

A

The latest price target for Insmed (NASDAQ:INSM) was reported by Goldman Sachs on June 11, 2025. The analyst firm set a price target for $112.00 expecting INSM to rise to within 12 months (a possible 13.13% upside). 47 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Insmed (INSM)?

A

The latest analyst rating for Insmed (NASDAQ:INSM) was provided by Goldman Sachs, and Insmed maintained their buy rating.

Q

When was the last upgrade for Insmed (INSM)?

A

There is no last upgrade for Insmed

Q

When was the last downgrade for Insmed (INSM)?

A

There is no last downgrade for Insmed.

Q

When is the next analyst rating going to be posted or updated for Insmed (INSM)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Insmed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Insmed was filed on June 11, 2025 so you should expect the next rating to be made available sometime around June 11, 2026.

Q

Is the Analyst Rating Insmed (INSM) correct?

A

While ratings are subjective and will change, the latest Insmed (INSM) rating was a maintained with a price target of $100.00 to $112.00. The current price Insmed (INSM) is trading at is $99.00, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch